BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yoshizawa H, Morishita Y, Watanabe M, Ishibashi K, Muto S, Kusano E, Nagata D. TGF-β₁-siRNA delivery with nanoparticles inhibits peritoneal fibrosis. Gene Ther 2015;22:333-40. [PMID: 25567535 DOI: 10.1038/gt.2014.116] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Huang Q, Xiao R, Lu J, Zhang Y, Xu L, Gao J, Sun J, Wang H. Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling. Front Pharmacol 2022;13:973182. [DOI: 10.3389/fphar.2022.973182] [Reference Citation Analysis]
2 Ding M, Huang Z, Wang X, Liu X, Xu L, Chen P, Liu J, Liu Y, Guan H, Chu Y, Liu H. Heparan sulfate proteoglycans-mediated targeted delivery of TGF-β1-binding peptide to liver for improved anti-liver fibrotic activity in vitro and in vivo. Int J Biol Macromol 2022;209:1516-25. [PMID: 35452701 DOI: 10.1016/j.ijbiomac.2022.04.085] [Reference Citation Analysis]
3 Yang L, Li Z, Chen Y, Chen F, Sun H, Zhao M, Chen Y, Wang Y, Li W, Zeng L, Bian Y, Hasnain MS. Elucidating the Novel Mechanism of Ligustrazine in Preventing Postoperative Peritoneal Adhesion Formation. Oxidative Medicine and Cellular Longevity 2022;2022:1-30. [DOI: 10.1155/2022/9226022] [Reference Citation Analysis]
4 Singh SK, Kumar U, Guleria A, Kumar D. A brief overview about the use of different bioactive liposome-based drug delivery systems in Peritoneal Dialysis and some other diseases. Nano Ex 2021;2:022006. [DOI: 10.1088/2632-959x/abfdd1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Luo XM, Yan C, Feng YM. Nanomedicine for the treatment of diabetes-associated cardiovascular diseases and fibrosis. Adv Drug Deliv Rev 2021;172:234-48. [PMID: 33417981 DOI: 10.1016/j.addr.2021.01.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Guo Y, Wang L, Gou R, Wang Y, Shi X, Zhang Y, Pang X, Tang L. Ameliorative role of SIRT1 in peritoneal fibrosis: an in vivo and in vitro study. Cell Biosci 2021;11:79. [PMID: 33906673 DOI: 10.1186/s13578-021-00591-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Bai H, Sun P, Wei S, Xie B, Li M, Xu Y, Wang W, Liu Y, Zhang L, Wu H, Wang Z, Xing Y, Wang Z, Li J. A novel intramural TGF β 1 hydrogel delivery method to decrease murine abdominal aortic aneurysm and rat aortic pseudoaneurysm formation and progression. Biomed Pharmacother 2021;137:111296. [PMID: 33545663 DOI: 10.1016/j.biopha.2021.111296] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
8 Nishimura K, Ogawa K, Kawaguchi M, Fumoto S, Mukai H, Kawakami S. Suppression of Peritoneal Fibrosis by Sonoporation of Hepatocyte Growth Factor Gene-Encoding Plasmid DNA in Mice. Pharmaceutics 2021;13:115. [PMID: 33477422 DOI: 10.3390/pharmaceutics13010115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Weng L, Funderburgh JL, Khandaker I, Geary ML, Yang T, Basu R, Funderburgh ML, Du Y, Yam GH. The anti-scarring effect of corneal stromal stem cell therapy is mediated by transforming growth factor β3. Eye Vis (Lond) 2020;7:52. [PMID: 33292650 DOI: 10.1186/s40662-020-00217-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
10 Balzer MS. Molecular pathways in peritoneal fibrosis. Cell Signal 2020;75:109778. [PMID: 32926960 DOI: 10.1016/j.cellsig.2020.109778] [Cited by in Crossref: 12] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
11 Zhao JL, Zhang T, Shao X, Zhu JJ, Guo MZ. Curcumin ameliorates peritoneal fibrosis via inhibition of transforming growth factor-activated kinase 1 (TAK1) pathway in a rat model of peritoneal dialysis. BMC Complement Altern Med 2019;19:280. [PMID: 31647008 DOI: 10.1186/s12906-019-2702-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
12 Li L, Shen N, Wang N, Wang W, Tang Q, Du X, Carrero JJ, Wang K, Deng Y, Li Z, Lin H, Wu T. Inhibiting core fucosylation attenuates glucose-induced peritoneal fibrosis in rats. Kidney International 2018;93:1384-96. [DOI: 10.1016/j.kint.2017.12.023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
13 Tamura R, Doi S, Nakashima A, Sasaki K, Maeda K, Ueno T, Masaki T. Inhibition of the H3K4 methyltransferase SET7/9 ameliorates peritoneal fibrosis. PLoS One 2018;13:e0196844. [PMID: 29723250 DOI: 10.1371/journal.pone.0196844] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
14 Zhou T, Li X, Li G, Tian T, Lin S, Shi S, Liao J, Cai X, Lin Y. Injectable and thermosensitive TGF-β1-loaded PCEC hydrogel system for in vivo cartilage repair. Sci Rep 2017;7:10553. [PMID: 28874815 DOI: 10.1038/s41598-017-11322-w] [Cited by in Crossref: 22] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
15 Miyazawa H, Hirai K, Ookawara S, Ishibashi K, Morishita Y. Nano-sized carriers in gene therapy for renal fibrosis in vivo. Nano Rev Exp 2017;8:1331099. [PMID: 30410705 DOI: 10.1080/20022727.2017.1331099] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
16 Igarashi Y, Morishita Y, Yoshizawa H, Imai R, Imai T, Hirahara I, Akimoto T, Ookawara S, Ishibashi K, Muto S, Nagata D. The association between soluble intercellular adhesion molecule-1 levels in drained dialysate and peritoneal injury in peritoneal dialysis. Ren Fail 2017;39:392-9. [PMID: 28201944 DOI: 10.1080/0886022X.2017.1287735] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
17 Liang G, Zhu Y, Jing A, Wang J, Hu F, Feng W, Xiao Z, Chen B. Cationic microRNA-delivering nanocarriers for efficient treatment of colon carcinoma in xenograft model. Gene Ther. 2016;23:829-838. [PMID: 27482839 DOI: 10.1038/gt.2016.60] [Cited by in Crossref: 34] [Cited by in F6Publishing: 40] [Article Influence: 5.7] [Reference Citation Analysis]
18 Zhou Q, Bajo MA, Del Peso G, Yu X, Selgas R. Preventing peritoneal membrane fibrosis in peritoneal dialysis patients. Kidney Int 2016;90:515-24. [PMID: 27282936 DOI: 10.1016/j.kint.2016.03.040] [Cited by in Crossref: 62] [Cited by in F6Publishing: 77] [Article Influence: 10.3] [Reference Citation Analysis]
19 Zhang Y, Wei L, Miron RJ, Shi B, Bian Z. Bone scaffolds loaded with siRNA-Semaphorin4d for the treatment of osteoporosis related bone defects. Sci Rep 2016;6:26925. [PMID: 27254469 DOI: 10.1038/srep26925] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
20 Fan YP, Hsia CC, Tseng KW, Liao CK, Fu TW, Ko TL, Chiu MM, Shih YH, Huang PY, Chiang YC, Yang CC, Fu YS. The Therapeutic Potential of Human Umbilical Mesenchymal Stem Cells From Wharton's Jelly in the Treatment of Rat Peritoneal Dialysis-Induced Fibrosis. Stem Cells Transl Med 2016;5:235-47. [PMID: 26718649 DOI: 10.5966/sctm.2015-0001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
21 Morishita Y, Yoshizawa H, Watanabe M, Imai R, Imai T, Hirahara I, Akimoto T, Ookawara S, Muto S, Nagata D. MicroRNA expression profiling in peritoneal fibrosis. Transl Res 2016;169:47-66. [PMID: 26616819 DOI: 10.1016/j.trsl.2015.10.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
22 Jiang X, Chen Y, Zhu H, Wang B, Qu P, Chen R, Sun X. Sodium Tanshinone IIA Sulfonate Ameliorates Bladder Fibrosis in a Rat Model of Partial Bladder Outlet Obstruction by Inhibiting the TGF-β/Smad Pathway Activation. PLoS One 2015;10:e0129655. [PMID: 26061047 DOI: 10.1371/journal.pone.0129655] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]